Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Purity | ≥98% |
---|---|
Formula | C33H59N11O10 |
Formula Wt. | 769.90 |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Akt inhibitor.
Nucleoside (guanosine) analog; RT, guanylyl cyc...
Synthetic steroid hormone; ER agonist.
Endogenous glycoprotein; lactoferrin agonist.
Active form of vitamin D, regulates dietary Ca2...
Bulgarialactone azaphilone
Amphibian tachykinin neuropeptide.
Cysteine derivative, antioxidant, ROS scavenger...
FGFR inhibitor.
Neuroprotective flavonoid
Cyclic depsipeptide is a secondary metabolite i...
Dibenzofuran produced by lichens.
Synthetic peptide, stimulates gastric acid secr...
Endogenous sterol component of animal cell memb...
Dihydrofolate reductase inhibitor.
Amino acid precursor of dopamine.
GHB agonist, D2/3 antagonist.
Imidazole; 14-α demethylase inhibitor, potenti...
14-α demethylase inhibitor.
H+/K+ ATPase inhibitor.